Randomized phase III trial comparing single-agent paclitaxel poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer Article

Industry Collaboration International Collaboration

cited authors

  • O'Brien, Mary E. R.; Socinski, Mark A.; Popovich, Alexander Y.; Bondarenko, Igor N.; Tomova, Antoaneta; Bilynskyi, Borys T.; Hotko, Yevhen S.; Ganul, Valentin L.; Kostinsky, Ippolit Y.; Eisenfeld, Amy J.; Sandalic, Larissa; Oldham, Fred B.; Bandstra, Bruce; Sandler, Alan B.; Singer, Jack W.

authors

Publication Date

  • July 1, 2008

webpage

published in

category

keywords

  • CT-2103
  • PPX
  • PS 2
  • non-small cell lung cancer
  • paclitaxel poliglumex
  • toxicity

start page

  • 728

end page

  • 734

volume

  • 3

issue

  • 7